South Korea
· Delayed Price · Currency is KRW Green Cross Medical Science Statistics
Total Valuation
Green Cross Medical Science has a market cap or net worth of KRW 86.83 billion. The enterprise value is 113.69 billion.
| Market Cap | 86.83B |
| Enterprise Value | 113.69B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Green Cross Medical Science has 21.71 million shares outstanding. The number of shares has increased by 765.73% in one year.
| Shares Outstanding | 21.71M |
| Shares Change (YoY) | +765.73% |
| Shares Change (QoQ) | -96.96% |
| Owned by Insiders (%) | 11.44% |
| Owned by Institutions (%) | n/a |
| Float | 10.46M |
Valuation Ratios
The trailing PE ratio is 271.47.
| PE Ratio | 271.47 |
| Forward PE | n/a |
| PS Ratio | 0.88 |
| PB Ratio | 2.37 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.39, with an EV/FCF ratio of -44.34.
| EV / Earnings | 96.66 |
| EV / Sales | 1.18 |
| EV / EBITDA | 26.39 |
| EV / EBIT | n/a |
| EV / FCF | -44.34 |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 81.11.
| Current Ratio | 0.96 |
| Quick Ratio | 0.58 |
| Debt / Equity | 81.11 |
| Debt / EBITDA | 7.17 |
| Debt / FCF | -12.05 |
| Interest Coverage | 0.11 |
Financial Efficiency
Return on equity (ROE) is 3.10% and return on invested capital (ROIC) is 0.36%.
| Return on Equity (ROE) | 3.10% |
| Return on Assets (ROA) | 0.24% |
| Return on Capital (ROIC) | 0.36% |
| Revenue Per Employee | 740.70M |
| Profits Per Employee | 9.05M |
| Employee Count | 130 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 4.97 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.42% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -8.42% |
| 50-Day Moving Average | 4,437.40 |
| 200-Day Moving Average | 4,322.68 |
| Relative Strength Index (RSI) | 40.34 |
| Average Volume (20 Days) | 1,605,454 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Green Cross Medical Science had revenue of KRW 96.29 billion and earned 1.18 billion in profits. Earnings per share was 14.73.
| Revenue | 96.29B |
| Gross Profit | 13.38B |
| Operating Income | 370.30M |
| Pretax Income | 1.16B |
| Net Income | 1.18B |
| EBITDA | 4.31B |
| EBIT | 370.30M |
| Earnings Per Share (EPS) | 14.73 |
Balance Sheet
The company has 6.47 billion in cash and 30.91 billion in debt, giving a net cash position of -24.44 billion or -1,125.91 per share.
| Cash & Cash Equivalents | 6.47B |
| Total Debt | 30.91B |
| Net Cash | -24.44B |
| Net Cash Per Share | -1,125.91 |
| Equity (Book Value) | 38.11B |
| Book Value Per Share | 1,691.01 |
| Working Capital | -1.98B |
Cash Flow
In the last 12 months, operating cash flow was 3.76 billion and capital expenditures -6.32 billion, giving a free cash flow of -2.56 billion.
| Operating Cash Flow | 3.76B |
| Capital Expenditures | -6.32B |
| Free Cash Flow | -2.56B |
| FCF Per Share | -118.12 |
Margins
Gross margin is 13.90%, with operating and profit margins of 0.38% and 1.22%.
| Gross Margin | 13.90% |
| Operating Margin | 0.38% |
| Pretax Margin | 1.20% |
| Profit Margin | 1.22% |
| EBITDA Margin | 4.47% |
| EBIT Margin | 0.38% |
| FCF Margin | -2.66% |
Dividends & Yields
Green Cross Medical Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -765.73% |
| Shareholder Yield | -765.73% |
| Earnings Yield | 0.37% |
| FCF Yield | -2.95% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |